Press Releases

Aug 10, 2026 6:00am EDT

Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

Jul 22, 2026 6:00am EDT

Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

Jul 20, 2026 6:00am EDT

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

Jul 16, 2026 7:30am EDT

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

Jul 09, 2026 6:00am EDT

Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01

Jun 01, 2026 8:15am EDT

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Jun 01, 2026 6:00am EDT

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

May 22, 2026 4:30pm EDT

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Apr 30, 2026 6:00am EDT

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Apr 23, 2026 6:00am EDT

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026